Elobixibat is a bile acid transporter inhibitor used in the treatment of chronic idiopathic constipation and dyslipidemia by limiting the intestinal reabsorption of bile acids. The compounds in this category,… Read more
![Chemical structure of ((2R)-2-(2-((3,3-Dibutyl-7-(methylthio)-1-oxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R-2-2-33-Dibutyl-7-methylthio-1-oxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycine.png&w=3840&q=75)
![Chemical structure of (2-(2-((3,3-Dibutyl-7-mercapto-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-2-33-Dibutyl-7-mercapto-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycine.png&w=3840&q=75)
![Chemical structure of (2R)-2-Phenyl-N-[(phenylmethoxy)carbonyl]glycyl-glycine 1,1-Dimethylethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F439088-73-0-2R-2-Phenyl-N-phenylmethoxycarbonylglycyl-glycine-11-Dimethylethyl-Ester.png&w=3840&q=75)
![Chemical structure of (R)-(2-(2-((3,3-Dibutyl-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-2-2-33-Dibutyl-7-methylthio-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycine.png&w=3840&q=75)
![Chemical structure of (R)-(2-(N-(tert-Butyl)-2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-2-N-tert-Butyl-2-33-dibutyl-7-methylthio-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycine.png&w=3840&q=75)
![Chemical structure of (R)-2-(2-((3,3-Dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F439086-76-7-R-2-2-33-Dibutyl-7-methylthio-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetic-acid.png&w=3840&q=75)
![Chemical structure of (R)-N-(tert-Butyl)-N-(2-(2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-N-tert-Butyl-N-2-2-33-dibutyl-7-methylthio-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycine.png&w=3840&q=75)
![Chemical structure of 2-((7-Bromo-3,3-dibutyl-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F358375-95-8-2-7-Bromo-33-dibutyl-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetic-Acid.png&w=3840&q=75)
![Chemical structure of 3,3-Dibutyl-8-hydroxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F439088-16-1-33-Dibutyl-8-hydroxy-7-methylthio-5-phenyl-2345-tetrahydrobenzob14thiazepine-11-dioxide.png&w=3840&q=75)
![Chemical structure of 3,3-Dibutyl-8-hydroxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,2,5]thiadiazepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2585066-38-0-33-Dibutyl-8-hydroxy-7-methylthio-5-phenyl-2345-tetrahydrobenzof125thiadiazepine-11-dioxide.png&w=3840&q=75)
![Chemical structure of 3,3-Dibutyl-8-methoxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,2,5]thiadiazepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F501692-61-1-33-Dibutyl-8-methoxy-7-methylthio-5-phenyl-2345-tetrahydrobenzof125thiadiazepine-11-dioxide.png&w=3840&q=75)

![Chemical structure of 7-Bromo-3,3-dibutyl-8-hydroxy-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F358376-04-2-7-Bromo-33-dibutyl-8-hydroxy-5-phenyl-2345-tetrahydrobenzob14thiazepine-11-dioxide.png&w=3840&q=75)

![Chemical structure of 7-Bromo-3,3-dibutyl-8-methoxy-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,2,5]thiadiazepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F501692-83-7-7-Bromo-33-dibutyl-8-methoxy-5-phenyl-2345-tetrahydrobenzof125thiadiazepine-11-dioxide.png&w=3840&q=75)















![Chemical structure of Ethyl 2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)Acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F439089-12-0-Ethyl-2-33-dibutyl-7-methylthio-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyAcetate.png&w=3840&q=75)
![Chemical structure of Ethyl 2-((7-bromo-3,3-dibutyl-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F358375-94-7-Ethyl-2-7-bromo-33-dibutyl-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetate.png&w=3840&q=75)
![Chemical structure of Methyl (R)-(2-(2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-R-2-2-33-dibutyl-7-methylthio-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycinate.png&w=3840&q=75)

![Chemical structure of Tert-butyl (R)-(2-(2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F439088-54-7-Tert-butyl-R-2-2-33-dibutyl-7-methylthio-11-dioxido-5-phenyl-2345-tetrahydrobenzob14thiazepin-8-yloxyacetamido-2-phenylacetylglycinate.png&w=3840&q=75)
Elobixibat is a bile acid transporter inhibitor used in the treatment of chronic idiopathic constipation and dyslipidemia by limiting the intestinal reabsorption of bile acids. The compounds in this category, including Elobixibat reference standards, related impurities, and metabolites, are critical tools for rigorous pharmaceutical analysis. Laboratories utilize these high-quality materials for impurity profiling, allowing for the precise identification and quantification of degradation products or synthetic by-products found in active pharmaceutical ingredients. Additionally, stable isotope labelled Elobixibat serves as an essential internal standard in mass spectrometry, facilitating accurate method validation and quality control during complex bioanalytical studies. By providing these specialized materials, researchers and quality control departments can ensure compliance with regulatory standards and maintain the safety and efficacy of the therapeutic agent throughout the drug development lifecycle.